Cafepharma Today

June 12 2025 - BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal
BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal
Medtronic recalls ventilators linked to 2 serious injuries, 1 death
Merck aims to plug dengue fever vaccine gap in US
RFK Jr. names some vaccine critics to key CDC committee after ousting entire panel
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Bristol-Myers blueprints a 2,500-worker campus in New Jersey
Fierce Biotech
Thursday, September 25, 2014 - 9:27am
tags:
Bristol-Myers Squibb, New Jersey
Generic Sovaldi makers could pocket upwards of $600m says analyst
In-Pharma Technologist
Thursday, September 25, 2014 - 9:25am
tags:
generics, Sovaldi, Gilead Sciences, hepatitis C, Mylan, Strides Arcolab, Cadila, Cipla, Hetero Labs, Ranbaxy, Sequent Scientific
Valeant pitches potential eye drug, research focus
Yahoo/AP
Thursday, September 25, 2014 - 9:22am
tags:
Valeant Pharmaceuticals, R&D, Vesneo, glaucoma
5 Orphan Drug Biotech Stocks to Buy With Big Upside Potential
24/7 Wall St
Thursday, September 25, 2014 - 9:20am
tags:
orphan drugs, Alnylam, Biomarin, Alexion, Isis Pharmaceuticals, Vertex Pharmaceuticals
Shares of Pacira drop as FDA warns on misleading ads for pain relieving injection Exparel
Yahoo/AP
Thursday, September 25, 2014 - 9:19am
tags:
Pacira, FDA, warnings, drug ads, EXPAREL
Top 100 Richest in India: India's Pharma Sector Mints Billionaires
Forbes
Thursday, September 25, 2014 - 9:02am
tags:
India
Boehringer Ingelheim Announces FDA Approval of Spiriva® Respimat® for the Maintenance Treatment of COPD
Marketwatch
Thursday, September 25, 2014 - 8:58am
tags:
Boehringer Ingelheim, FDA, Spiriva, COPD
Valeant Shares Vault Higher, Boosting Allergan Bid Again
WSJ Online
Thursday, September 25, 2014 - 7:39am
tags:
Valeant Pharmaceuticals, M&A, Allergan
Novartis Says Psoriasis Drug Met End-Goal of Arthritis Studies
Bloomberg
Thursday, September 25, 2014 - 7:38am
tags:
Novartis, psoriasis, secukinumab, psoriatic arthritis
As Doctors Lose Clout, Drug Firms Redirect the Sales Call
WSJ Online
Thursday, September 25, 2014 - 7:37am
tags:
physicians, drug reps, formulary
Shire pays $56.5M to resolve whistleblower claims it improperly marketed drugs
Bizjournals.com
Wednesday, September 24, 2014 - 10:14pm
tags:
Shire, ADHD, False Claims Act, Adderall XR, Vyvanse, whistleblower lawsuits
Novavax's Influenza Vaccine Study Shows Adjuvant Efficiency
Yahoo/Zacks.com
Wednesday, September 24, 2014 - 9:44pm
tags:
Novavax, vaccines, flu vaccine, H7N9, H7N9 VLP
Adaptimmune raises $104 mln to develop immune-system cancer drugs
Yahoo/Reuters
Wednesday, September 24, 2014 - 9:39pm
tags:
Adaptimmune, immuno-oncology
Gilead's New HIV Drug Key To Long-Term Strategy
Investors.com
Wednesday, September 24, 2014 - 6:43pm
tags:
Gilead Sciences, HIV, tenofovir
Pfizer will ask FDA to remove "black box" suicide warning from its anti-smoking medication
Yahoo/AP
Wednesday, September 24, 2014 - 6:41pm
tags:
Pfizer, Chantix, black box, FDA, smoking cessation
When It Comes To Its Reputation, The Pharmaceutical Industry Continues To Mess Up
Forbes
Wednesday, September 24, 2014 - 4:01pm
tags:
Physician Payment Sunshine Act, physician payments
GlaxoSmithKline set to name Philip Hampton as next chairman: report
First Word Pharma
Wednesday, September 24, 2014 - 11:26am
tags:
GSK
Zimmer and Biomet update on their mega-merger
Mass Device
Wednesday, September 24, 2014 - 11:25am
tags:
Zimmer, Biomet, M&A, devices
Acorda Rises Most Since 2011 on $525 Million Civitas Deal
Bloomberg
Wednesday, September 24, 2014 - 11:23am
tags:
Acorda, M&A, Parkinson's Disease, Civitas
Valeant offers olive branch to Allergan
Marketwatch
Wednesday, September 24, 2014 - 11:22am
tags:
Allergan, M&A, Bill Ackman, Valeant Pharmaceuticals

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Vaccine Advice, Vandalized
In the Pipeline
Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.